Sort
85,873 grants matching “alzheimers”
APOE4 dependent regulation of CSF Complement Pathway Activation in the development of Alzheimer's Disease
$784,720Miles Berger · Duke University · R01 · FY2023 · AG
Establishment of a causal link between AD and L1 retrotransposons
$784,679Alysson R. Muotri · University Of California, San Diego · R01 · FY2023 · AG
Biology of Prion Protein and the TSE Diseases
$784,671Bruce Chesebro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Evaluating a National Person-Centered Training Program to Strengthen the Dementia Care Workforce
$784,653Sheryl Zimmerman · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AG
CORE--CLINICAL
$784,652Martin Rhys Farlow · Indiana University Indianapolis · P30 · FY2010 · AG
Development of GCPII inhibitors for the treatment of age-related cognitive disorders
$784,616Takashi Tsukamoto · Johns Hopkins University · R01 · FY2023 · AG
Comprehensive and Cell Type-Specific Proteogenomic Profiling of Aberrant and Mis-Processed Proteins in Alzheimer's Disease and Tauopathy Models
$784,596Nikolai Slavov · Northeastern University · R01 · FY2025 · AG
Mechanisms of Prion Protein Toxicity
$784,573David A Harris · Boston University Medical Campus · R01 · FY2022 · NS
Illuminating our understanding of statins and Alzheimers Disease and Dementia using modern causal inference methods
$784,514Adina Zeki Al Hazzouri · Columbia University Health Sciences · R01 · FY2025 · AG
Primary Progressive Aphasia: Cognition, Anatomy and Progression
$784,402Maria Luisa Gorno Tempini · University Of California, San Francisco · R01 · FY2019 · NS
Molecular Genetic Insight into Neurodegenerative Disease from Drosophila
$784,363Nancy M Bonini · University Of Pennsylvania · R35 · FY2023 · NS
Depression and Alzheimer's Disease: CaTAUstrophy?
$784,324Jennifer Rose Gatchel · Massachusetts General Hospital · R01 · FY2024 · AG
Translational Geroscience Network
$784,286James L. Kirkland · Mayo Clinic Rochester · R33 · FY2023 · AG
TRiPOD: Toward Reusable Phenotypes in Observational Data for AD/ADRD - managing definitions and correcting bias
$784,272Yong Chen · University Of Pennsylvania · R01 · FY2023 · AG
Vascular Mechanisms of Dementia: Cell-Type Specific Therapeutic and Imaging Strategies
$784,245Jaime Grutzendler · Yale University · R01 · FY2025 · NS
Biological Aging Contributions to Molecular Pathology and Neurodegeneration
$784,211Corey T McMillan · University Of Pennsylvania · R01 · FY2019 · AG
Novel Extracorporeal Device 'Amytrapper' To Remove Beta Amyloid In Alzheimer'sDisease
$784,203Pazhani Sundaram · Recombinant Technologies, Llc · R44 · FY2024 · AG
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
$784,183Miles Berger · Duke University · R01 · FY2022 · AG
RETAIN: A digital therapeutic for Alzheimer's risk reduction
$784,098Mark McInnis · Retain Health Inc · R44 · FY2023 · AG
Long-Term Nicotine Treatment of Mild Cognitive Impairment - Bridge Funding
$784,085Paul A. Newhouse · Vanderbilt University Medical Center · R01 · FY2020 · AG
Impaired activity-dependent protein synthesis in dendrites and pathophysiology in tauopathy
$784,070Tara Tracy · Buck Institute For Research On Aging · R01 · FY2023 · AG
First-in-Human evaluation of an astrocytic glutamate transporter (EAAT2) PET tracer in healthy and Alzheimer's diseased brain
$784,058David M Wilson · University Of California, San Francisco · R01 · FY2022 · AG
Protective genetic factors of Alzheimer disease in PSEN1 Mutation Carriers in Puerto Rico
$784,029Joseph Hyungwoo Lee · Columbia University Health Sciences · R01 · FY2019 · AG
The risks and consequences of a motor vehicle crash in older adults with Alzheimer's Disease and Related Dementias
$784,027Nina Joyce · Brown University · R01 · FY2022 · AG
Cognitive Computing of Alzheimer's Disease Genes and Risk
$783,998Olivier Lichtarge · Baylor College Of Medicine · U01 · FY2025 · AG